Newsroom
153 articles
Featured The Medicines and Healthcare Products Regulatory Agency (MHRA) is advising medical practitioners to make sure patients are informed about the known adverse effects of agonists of the glucagon-like…
Featured Sugemalimab, also known as(Equijubi), has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat adult patients with “non-small cell lung cancer.” Non-small cell lung…
Featured The Medicines and Healthcare Products Regulatory Agency (MHRA) has authorized elafibranor (Iqirvo) for the treatment of adult patients suffering from primary biliary cholangitis (PBC), a rare form of…
Featured Hympavzi (marstacimab-hncq) was approved by the U.S. Food and Drug Administration for routine prophylactic use in patients aged 12 and up who have hemophilia A without factor VIII…
Featured An adult COVID-19 vaccine (Comirnaty) that targets the KP.2 subvariant has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA). The immune system’s generation of antibodies…
Featured Patients who use insulin pumps or continuous glucose monitors (CGMs) are being asked by the Medicines and Healthcare Products Regulatory Agency (MHRA) to promptly report any safety issues…
Featured Marketing permission for the Healgen Rapid Check COVID-19/Flu A&B Antigen Test was given by the U.S. Food and Drug Administration. The test is approved for use without a…
Featured The Medicines and Healthcare products Regulatory Agency (MHRA) has approved leniolisib phosphate (Joenja) to treat a rare immune disease known as activated phosphoinositide 3-kinase delta syndrome or APDS…
Featured Steps to maximize the utilization of EU’s specialized resources for expedited evaluations, working together, the European Medicines Agency (EMA) and the European Medicines Regulatory Network aim to increase…
Featured Cobenfy (xanomeline and trospium chloride) capsules have been approved by the US Food and Drug Administration for oral use in the treatment of adult schizophrenia. Unlike the long-established…
Featured The Medicines and Healthcare products Regulatory Agency (MHRA) approved the new medicine fruquintinib (Fruzaqla) to care for adult patients who have colorectal cancer that has spread (CRC). When…
Featured The U.S. Food and Drug Administration approved FluMist for self- or caregiver-administration. FluMist is authorized for the prevention of influenza in those ages 2 to 49 who are…
Featured MHRA launches a new strategy aims to transform the way we provide information on the risks and safety of medicines and medical devices. The Medicines and Healthcare products…
Featured Following a thorough review, the Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the available evidence does not establish a causal relationship between Glucagon-Like Peptide-1 (GLP-1)…
Featured EMA’s safety committee, PRAC, has recommended measures to minimize the serious outcomes of agranulocytosis, a known side effect caused by the painkiller metamizole. Agranulocytosis involves a sudden and…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP